Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00052
Full Text
Open PDFAbstract
Available in full text
Date
February 14, 2019
Authors
Publisher
Frontiers Media SA